 | • レポートコード：GIR-107A14640 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、化学療法誘発性貧血治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。化学療法誘発性貧血治療薬の種類別市場規模（エポエチンゼータバイオシミラー、第二鉄カルボキシマルトース、ペグ化エリスロポエチン、その他）、用途別市場規模（診療所、病院、在宅医療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・化学療法誘発性貧血治療薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：3SBio Inc.、BIOCAD、Chong Kun Dang Pharmaceutical Corp.、Dr. Reddy's Laboratories Limited、Galenica Ltd.、Panacea Biotec Limited、Pfizer Inc.、PharmaEssentia Corporation、PhytoHealth Corporation、Pieris Pharmaceuticals Inc、Sandoz International GmbH、SBI Pharmaceuticals Co., Ltd.、Therapure Biopharma Inc.、Tolero Pharmaceuticals, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：エポエチンゼータバイオシミラー、第二鉄カルボキシマルトース、ペグ化エリスロポエチン、その他 ・用途別分析2016年-2026年：診療所、病院、在宅医療 ・化学療法誘発性貧血治療薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・化学療法誘発性貧血治療薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・化学療法誘発性貧血治療薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・化学療法誘発性貧血治療薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・化学療法誘発性貧血治療薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Chemotherapy Induced Anemia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Chemotherapy Induced Anemia Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Chemotherapy Induced Anemia Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Chemotherapy Induced Anemia Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Epoetin Zeta Biosimilar
Ferric Carboxymaltose
Pegylated Erythropoietin
Others
Market segment by Application can be divided into
Clinic
Hospital
Homecare
The key market players for global Chemotherapy Induced Anemia Drug market are listed below:
3SBio Inc.
BIOCAD
Chong Kun Dang Pharmaceutical Corp.
Dr. Reddy’s Laboratories Limited
Galenica Ltd.
Panacea Biotec Limited
Pfizer Inc.
PharmaEssentia Corporation
PhytoHealth Corporation
Pieris Pharmaceuticals Inc
Sandoz International GmbH
SBI Pharmaceuticals Co., Ltd.
Therapure Biopharma Inc.
Tolero Pharmaceuticals, Inc.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Chemotherapy Induced Anemia Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chemotherapy Induced Anemia Drug, with price, sales, revenue and global market share of Chemotherapy Induced Anemia Drug from 2019 to 2021.
Chapter 3, the Chemotherapy Induced Anemia Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chemotherapy Induced Anemia Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Chemotherapy Induced Anemia Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Chemotherapy Induced Anemia Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Chemotherapy Induced Anemia Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Chemotherapy Induced Anemia Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Epoetin Zeta Biosimilar
1.2.3 Ferric Carboxymaltose
1.2.4 Pegylated Erythropoietin
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Chemotherapy Induced Anemia Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Chemotherapy Induced Anemia Drug Market Size & Forecast
1.4.1 Global Chemotherapy Induced Anemia Drug Sales in Value (2016-2026))
1.4.2 Global Chemotherapy Induced Anemia Drug Sales in Volume (2016-2026)
1.4.3 Global Chemotherapy Induced Anemia Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Chemotherapy Induced Anemia Drug Production Capacity Analysis
1.5.1 Global Chemotherapy Induced Anemia Drug Total Production Capacity (2016-2026)
1.5.2 Global Chemotherapy Induced Anemia Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Chemotherapy Induced Anemia Drug Market Drivers
1.6.2 Chemotherapy Induced Anemia Drug Market Restraints
1.6.3 Chemotherapy Induced Anemia Drug Trends Analysis
2 Manufacturers Profiles
2.1 3SBio Inc.
2.1.1 3SBio Inc. Details
2.1.2 3SBio Inc. Major Business
2.1.3 3SBio Inc. Chemotherapy Induced Anemia Drug Product and Services
2.1.4 3SBio Inc. Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 BIOCAD
2.2.1 BIOCAD Details
2.2.2 BIOCAD Major Business
2.2.3 BIOCAD Chemotherapy Induced Anemia Drug Product and Services
2.2.4 BIOCAD Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Chong Kun Dang Pharmaceutical Corp.
2.3.1 Chong Kun Dang Pharmaceutical Corp. Details
2.3.2 Chong Kun Dang Pharmaceutical Corp. Major Business
2.3.3 Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Product and Services
2.3.4 Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Dr. Reddy’s Laboratories Limited
2.4.1 Dr. Reddy’s Laboratories Limited Details
2.4.2 Dr. Reddy’s Laboratories Limited Major Business
2.4.3 Dr. Reddy’s Laboratories Limited Chemotherapy Induced Anemia Drug Product and Services
2.4.4 Dr. Reddy’s Laboratories Limited Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Galenica Ltd.
2.5.1 Galenica Ltd. Details
2.5.2 Galenica Ltd. Major Business
2.5.3 Galenica Ltd. Chemotherapy Induced Anemia Drug Product and Services
2.5.4 Galenica Ltd. Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Panacea Biotec Limited
2.6.1 Panacea Biotec Limited Details
2.6.2 Panacea Biotec Limited Major Business
2.6.3 Panacea Biotec Limited Chemotherapy Induced Anemia Drug Product and Services
2.6.4 Panacea Biotec Limited Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Pfizer Inc.
2.7.1 Pfizer Inc. Details
2.7.2 Pfizer Inc. Major Business
2.7.3 Pfizer Inc. Chemotherapy Induced Anemia Drug Product and Services
2.7.4 Pfizer Inc. Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 PharmaEssentia Corporation
2.8.1 PharmaEssentia Corporation Details
2.8.2 PharmaEssentia Corporation Major Business
2.8.3 PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Product and Services
2.8.4 PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 PhytoHealth Corporation
2.9.1 PhytoHealth Corporation Details
2.9.2 PhytoHealth Corporation Major Business
2.9.3 PhytoHealth Corporation Chemotherapy Induced Anemia Drug Product and Services
2.9.4 PhytoHealth Corporation Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Pieris Pharmaceuticals Inc
2.10.1 Pieris Pharmaceuticals Inc Details
2.10.2 Pieris Pharmaceuticals Inc Major Business
2.10.3 Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Product and Services
2.10.4 Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Sandoz International GmbH
2.11.1 Sandoz International GmbH Details
2.11.2 Sandoz International GmbH Major Business
2.11.3 Sandoz International GmbH Chemotherapy Induced Anemia Drug Product and Services
2.11.4 Sandoz International GmbH Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 SBI Pharmaceuticals Co., Ltd.
2.12.1 SBI Pharmaceuticals Co., Ltd. Details
2.12.2 SBI Pharmaceuticals Co., Ltd. Major Business
2.12.3 SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Product and Services
2.12.4 SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Therapure Biopharma Inc.
2.13.1 Therapure Biopharma Inc. Details
2.13.2 Therapure Biopharma Inc. Major Business
2.13.3 Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Product and Services
2.13.4 Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Tolero Pharmaceuticals, Inc.
2.14.1 Tolero Pharmaceuticals, Inc. Details
2.14.2 Tolero Pharmaceuticals, Inc. Major Business
2.14.3 Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Product and Services
2.14.4 Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Chemotherapy Induced Anemia Drug Sales by Manufacturer
3.1 Global Chemotherapy Induced Anemia Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Chemotherapy Induced Anemia Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Chemotherapy Induced Anemia Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Chemotherapy Induced Anemia Drug Manufacturer Market Share
3.4.2 Top 6 Chemotherapy Induced Anemia Drug Manufacturer Market Share
3.5 Global Chemotherapy Induced Anemia Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Chemotherapy Induced Anemia Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Chemotherapy Induced Anemia Drug Market Size by Region
4.1.1 Global Chemotherapy Induced Anemia Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Chemotherapy Induced Anemia Drug Revenue by Region (2016-2026)
4.2 North America Chemotherapy Induced Anemia Drug Revenue (2016-2026)
4.3 Europe Chemotherapy Induced Anemia Drug Revenue (2016-2026)
4.4 Asia-Pacific Chemotherapy Induced Anemia Drug Revenue (2016-2026)
4.5 South America Chemotherapy Induced Anemia Drug Revenue (2016-2026)
4.6 Middle East and Africa Chemotherapy Induced Anemia Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Chemotherapy Induced Anemia Drug Sales in Volume by Type (2016-2026)
5.2 Global Chemotherapy Induced Anemia Drug Revenue by Type (2016-2026)
5.3 Global Chemotherapy Induced Anemia Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Chemotherapy Induced Anemia Drug Sales in Volume by Application (2016-2026)
6.2 Global Chemotherapy Induced Anemia Drug Revenue by Application (2016-2026)
6.3 Global Chemotherapy Induced Anemia Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Chemotherapy Induced Anemia Drug Sales by Type (2016-2026)
7.2 North America Chemotherapy Induced Anemia Drug Sales by Application (2016-2026)
7.3 North America Chemotherapy Induced Anemia Drug Market Size by Country
7.3.1 North America Chemotherapy Induced Anemia Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Chemotherapy Induced Anemia Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Chemotherapy Induced Anemia Drug Sales by Type (2016-2026)
8.2 Europe Chemotherapy Induced Anemia Drug Sales by Application (2016-2026)
8.3 Europe Chemotherapy Induced Anemia Drug Market Size by Country
8.3.1 Europe Chemotherapy Induced Anemia Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Chemotherapy Induced Anemia Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Chemotherapy Induced Anemia Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Chemotherapy Induced Anemia Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Chemotherapy Induced Anemia Drug Market Size by Region
9.3.1 Asia-Pacific Chemotherapy Induced Anemia Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Chemotherapy Induced Anemia Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Chemotherapy Induced Anemia Drug Sales by Type (2016-2026)
10.2 South America Chemotherapy Induced Anemia Drug Sales by Application (2016-2026)
10.3 South America Chemotherapy Induced Anemia Drug Market Size by Country
10.3.1 South America Chemotherapy Induced Anemia Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Chemotherapy Induced Anemia Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Chemotherapy Induced Anemia Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Chemotherapy Induced Anemia Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Chemotherapy Induced Anemia Drug Market Size by Country
11.3.1 Middle East & Africa Chemotherapy Induced Anemia Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Chemotherapy Induced Anemia Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Chemotherapy Induced Anemia Drug Typical Distributors
12.3 Chemotherapy Induced Anemia Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Chemotherapy Induced Anemia Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Chemotherapy Induced Anemia Drug Revenue by Application, (USD Million), 2021-2026
Table 3. 3SBio Inc. Basic Information, Manufacturing Base and Competitors
Table 4. 3SBio Inc. Major Business
Table 5. 3SBio Inc. Chemotherapy Induced Anemia Drug Product and Services
Table 6. 3SBio Inc. Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. BIOCAD Basic Information, Manufacturing Base and Competitors
Table 8. BIOCAD Major Business
Table 9. BIOCAD Chemotherapy Induced Anemia Drug Product and Services
Table 10. BIOCAD Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Chong Kun Dang Pharmaceutical Corp. Basic Information, Manufacturing Base and Competitors
Table 12. Chong Kun Dang Pharmaceutical Corp. Major Business
Table 13. Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Product and Services
Table 14. Chong Kun Dang Pharmaceutical Corp. Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Dr. Reddy's Laboratories Limited Basic Information, Manufacturing Base and Competitors
Table 16. Dr. Reddy's Laboratories Limited Major Business
Table 17. Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Product and Services
Table 18. Dr. Reddy's Laboratories Limited Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Galenica Ltd. Basic Information, Manufacturing Base and Competitors
Table 20. Galenica Ltd. Major Business
Table 21. Galenica Ltd. Chemotherapy Induced Anemia Drug Product and Services
Table 22. Galenica Ltd. Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Panacea Biotec Limited Basic Information, Manufacturing Base and Competitors
Table 24. Panacea Biotec Limited Major Business
Table 25. Panacea Biotec Limited Chemotherapy Induced Anemia Drug Product and Services
Table 26. Panacea Biotec Limited Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 28. Pfizer Inc. Major Business
Table 29. Pfizer Inc. Chemotherapy Induced Anemia Drug Product and Services
Table 30. Pfizer Inc. Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. PharmaEssentia Corporation Basic Information, Manufacturing Base and Competitors
Table 32. PharmaEssentia Corporation Major Business
Table 33. PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Product and Services
Table 34. PharmaEssentia Corporation Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. PhytoHealth Corporation Basic Information, Manufacturing Base and Competitors
Table 36. PhytoHealth Corporation Major Business
Table 37. PhytoHealth Corporation Chemotherapy Induced Anemia Drug Product and Services
Table 38. PhytoHealth Corporation Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Pieris Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 40. Pieris Pharmaceuticals Inc Major Business
Table 41. Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Product and Services
Table 42. Pieris Pharmaceuticals Inc Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sandoz International GmbH Basic Information, Manufacturing Base and Competitors
Table 44. Sandoz International GmbH Major Business
Table 45. Sandoz International GmbH Chemotherapy Induced Anemia Drug Product and Services
Table 46. Sandoz International GmbH Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. SBI Pharmaceuticals Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 48. SBI Pharmaceuticals Co., Ltd. Major Business
Table 49. SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Product and Services
Table 50. SBI Pharmaceuticals Co., Ltd. Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Therapure Biopharma Inc. Basic Information, Manufacturing Base and Competitors
Table 52. Therapure Biopharma Inc. Major Business
Table 53. Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Product and Services
Table 54. Therapure Biopharma Inc. Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Tolero Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 56. Tolero Pharmaceuticals, Inc. Major Business
Table 57. Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Product and Services
Table 58. Tolero Pharmaceuticals, Inc. Chemotherapy Induced Anemia Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Global Chemotherapy Induced Anemia Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 60. Global Chemotherapy Induced Anemia Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 61. Market Position of Manufacturers in Chemotherapy Induced Anemia Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 62. Global Chemotherapy Induced Anemia Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 63. Head Office and Chemotherapy Induced Anemia Drug Production Site of Key Manufacturer
Table 64. Chemotherapy Induced Anemia Drug New Entrant and Capacity Expansion Plans
Table 65. Chemotherapy Induced Anemia Drug Mergers & Acquisitions in the Past Five Years
Table 66. Global Chemotherapy Induced Anemia Drug Sales by Region (2016-2021e) & (K Pcs)
Table 67. Global Chemotherapy Induced Anemia Drug Sales by Region (2021-2026) & (K Pcs)
Table 68. Global Chemotherapy Induced Anemia Drug Revenue by Region (2016-2021e) & (USD Million)
Table 69. Global Chemotherapy Induced Anemia Drug Revenue by Region (2021-2026) & (USD Million)
Table 70. Global Chemotherapy Induced Anemia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 71. Global Chemotherapy Induced Anemia Drug Sales by Type (2021-2026) & (K Pcs)
Table 72. Global Chemotherapy Induced Anemia Drug Revenue by Type (2016-2021e) & (USD Million)
Table 73. Global Chemotherapy Induced Anemia Drug Revenue by Type (2021-2026) & (USD Million)
Table 74. Global Chemotherapy Induced Anemia Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 75. Global Chemotherapy Induced Anemia Drug Price by Type (2021-2026) & (USD/Pcs)
Table 76. Global Chemotherapy Induced Anemia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 77. Global Chemotherapy Induced Anemia Drug Sales by Application (2021-2026) & (K Pcs)
Table 78. Global Chemotherapy Induced Anemia Drug Revenue by Application (2016-2021e) & (USD Million)
Table 79. Global Chemotherapy Induced Anemia Drug Revenue by Application (2021-2026) & (USD Million)
Table 80. Global Chemotherapy Induced Anemia Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 81. Global Chemotherapy Induced Anemia Drug Price by Application (2021-2026) & (USD/Pcs)
Table 82. North America Chemotherapy Induced Anemia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 83. North America Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (K Pcs)
Table 84. North America Chemotherapy Induced Anemia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 85. North America Chemotherapy Induced Anemia Drug Revenue by Country (2021-2026) & (USD Million)
Table 86. North America Chemotherapy Induced Anemia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 87. North America Chemotherapy Induced Anemia Drug Sales by Type (2021-2026) & (K Pcs)
Table 88. North America Chemotherapy Induced Anemia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 89. North America Chemotherapy Induced Anemia Drug Sales by Application (2021-2026) & (K Pcs)
Table 90. Europe Chemotherapy Induced Anemia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 91. Europe Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (K Pcs)
Table 92. Europe Chemotherapy Induced Anemia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 93. Europe Chemotherapy Induced Anemia Drug Revenue by Country (2021-2026) & (USD Million)
Table 94. Europe Chemotherapy Induced Anemia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 95. Europe Chemotherapy Induced Anemia Drug Sales by Type (2021-2026) & (K Pcs)
Table 96. Europe Chemotherapy Induced Anemia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 97. Europe Chemotherapy Induced Anemia Drug Sales by Application (2021-2026) & (K Pcs)
Table 98. Asia-Pacific Chemotherapy Induced Anemia Drug Sales by Region (2016-2021e) & (K Pcs)
Table 99. Asia-Pacific Chemotherapy Induced Anemia Drug Sales by Region (2021-2026) & (K Pcs)
Table 100. Asia-Pacific Chemotherapy Induced Anemia Drug Revenue by Region (2016-2021e) & (USD Million)
Table 101. Asia-Pacific Chemotherapy Induced Anemia Drug Revenue by Region (2021-2026) & (USD Million)
Table 102. Asia-Pacific Chemotherapy Induced Anemia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 103. Asia-Pacific Chemotherapy Induced Anemia Drug Sales by Type (2021-2026) & (K Pcs)
Table 104. Asia-Pacific Chemotherapy Induced Anemia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 105. Asia-Pacific Chemotherapy Induced Anemia Drug Sales by Application (2021-2026) & (K Pcs)
Table 106. South America Chemotherapy Induced Anemia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 107. South America Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (K Pcs)
Table 108. South America Chemotherapy Induced Anemia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 109. South America Chemotherapy Induced Anemia Drug Revenue by Country (2021-2026) & (USD Million)
Table 110. South America Chemotherapy Induced Anemia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 111. South America Chemotherapy Induced Anemia Drug Sales by Type (2021-2026) & (K Pcs)
Table 112. South America Chemotherapy Induced Anemia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 113. South America Chemotherapy Induced Anemia Drug Sales by Application (2021-2026) & (K Pcs)
Table 114. Middle East & Africa Chemotherapy Induced Anemia Drug Sales by Country (2016-2021e) & (K Pcs)
Table 115. Middle East & Africa Chemotherapy Induced Anemia Drug Sales by Country (2021-2026) & (K Pcs)
Table 116. Middle East & Africa Chemotherapy Induced Anemia Drug Revenue by Country (2016-2021e) & (USD Million)
Table 117. Middle East & Africa Chemotherapy Induced Anemia Drug Revenue by Country (2021-2026) & (USD Million)
Table 118. Middle East & Africa Chemotherapy Induced Anemia Drug Sales by Type (2016-2021e) & (K Pcs)
Table 119. Middle East & Africa Chemotherapy Induced Anemia Drug Sales by Type (2021-2026) & (K Pcs)
Table 120. Middle East & Africa Chemotherapy Induced Anemia Drug Sales by Application (2016-2021e) & (K Pcs)
Table 121. Middle East & Africa Chemotherapy Induced Anemia Drug Sales by Application (2021-2026) & (K Pcs)
Table 122. Direct Channel Pros & Cons
Table 123. Indirect Channel Pros & Cons
Table 124. Chemotherapy Induced Anemia Drug Typical Distributors
Table 125. Chemotherapy Induced Anemia Drug Typical Customers
List of Figures
Figure 1. Chemotherapy Induced Anemia Drug Picture
Figure 2. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type in 2020
Figure 3. Epoetin Zeta Biosimilar
Figure 4. Ferric Carboxymaltose
Figure 5. Pegylated Erythropoietin
Figure 6. Others
Figure 7. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application in 2020
Figure 8. Clinic
Figure 9. Hospital
Figure 10. Homecare
Figure 11. Global Chemotherapy Induced Anemia Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 12. Global Chemotherapy Induced Anemia Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. Global Chemotherapy Induced Anemia Drug Sales (2016-2026) & (K Pcs)
Figure 14. Global Chemotherapy Induced Anemia Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 15. Global Chemotherapy Induced Anemia Drug Production Capacity (2016-2026) & (K Pcs)
Figure 16. Global Chemotherapy Induced Anemia Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 17. Chemotherapy Induced Anemia Drug Market Drivers
Figure 18. Chemotherapy Induced Anemia Drug Market Restraints
Figure 19. Chemotherapy Induced Anemia Drug Market Trends
Figure 20. Global Chemotherapy Induced Anemia Drug Sales Market Share by Manufacturer in 2020
Figure 21. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Manufacturer in 2020
Figure 22. Chemotherapy Induced Anemia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 23. Top 3 Chemotherapy Induced Anemia Drug Manufacturer (Revenue) Market Share in 2020
Figure 24. Top 6 Chemotherapy Induced Anemia Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Global Chemotherapy Induced Anemia Drug Sales Market Share by Region (2016-2026)
Figure 26. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Region (2016-2026)
Figure 27. North America Chemotherapy Induced Anemia Drug Revenue (2016-2026) & (USD Million)
Figure 28. Europe Chemotherapy Induced Anemia Drug Revenue (2016-2026) & (USD Million)
Figure 29. Asia-Pacific Chemotherapy Induced Anemia Drug Revenue (2016-2026) & (USD Million)
Figure 30. South America Chemotherapy Induced Anemia Drug Revenue (2016-2026) & (USD Million)
Figure 31. Middle East & Africa Chemotherapy Induced Anemia Drug Revenue (2016-2026) & (USD Million)
Figure 32. Global Chemotherapy Induced Anemia Drug Sales Market Share by Type (2016-2026)
Figure 33. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Type (2016-2026)
Figure 34. Global Chemotherapy Induced Anemia Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 35. Global Chemotherapy Induced Anemia Drug Sales Market Share by Application (2016-2026)
Figure 36. Global Chemotherapy Induced Anemia Drug Revenue Market Share by Application (2016-2026)
Figure 37. Global Chemotherapy Induced Anemia Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 38. North America Chemotherapy Induced Anemia Drug Sales Market Share by Type (2016-2026)
Figure 39. North America Chemotherapy Induced Anemia Drug Sales Market Share by Application (2016-2026)
Figure 40. North America Chemotherapy Induced Anemia Drug Sales Market Share by Country (2016-2026)
Figure 41. North America Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2016-2026)
Figure 42. United States Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Chemotherapy Induced Anemia Drug Sales Market Share by Type (2016-2026)
Figure 46. Europe Chemotherapy Induced Anemia Drug Sales Market Share by Application (2016-2026)
Figure 47. Europe Chemotherapy Induced Anemia Drug Sales Market Share by Country (2016-2026)
Figure 48. Europe Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2016-2026)
Figure 49. Germany Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Chemotherapy Induced Anemia Drug Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Chemotherapy Induced Anemia Drug Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Chemotherapy Induced Anemia Drug Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Chemotherapy Induced Anemia Drug Revenue Market Share by Region (2016-2026)
Figure 58. China Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Japan Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Korea Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. India Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Southeast Asia Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Australia Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. South America Chemotherapy Induced Anemia Drug Sales Market Share by Type (2016-2026)
Figure 65. South America Chemotherapy Induced Anemia Drug Sales Market Share by Application (2016-2026)
Figure 66. South America Chemotherapy Induced Anemia Drug Sales Market Share by Country (2016-2026)
Figure 67. South America Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East & Africa Chemotherapy Induced Anemia Drug Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Chemotherapy Induced Anemia Drug Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Chemotherapy Induced Anemia Drug Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Chemotherapy Induced Anemia Drug Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Egypt Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. South Africa Chemotherapy Induced Anemia Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
世界の化学療法誘発性好中球減少症治療薬市場 2021：企業別、地域別、種類・用途別 The Chemotherapy Induced Neutropenia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- 世界の化学療法誘発性骨髄抑制治療市場 2021：企業別、地域別、種類・用途別 The Chemotherapy-Induced Myelosuppression Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 世界の化学療法誘発性脱毛用頭皮クール機器市場 2021：企業別、地域別、種類・用途別 The Scalp Cool Devices for Chemotherapy Induced Hair Loss market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- 世界の化学療法誘発性末梢神経障害治療市場 2021：企業別、地域別、種類・用途別 The Chemotherapy Induced Peripheral Neuropathy Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chai…
- 世界のファンコニ貧血治療薬市場 2021：企業別、地域別、種類・用途別 The Fanconi Anemia Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…